Literature DB >> 12053047

Neonatal subependymal giant cell astrocytoma.

Azedine Medhkour1, David Traul, Muhammad Husain.   

Abstract

Subependymal giant cell astrocytoma (SEGCA) is a benign, slow-growing glial tumor that manifests with signs and symptoms of obstructive hydrocephalus most often in adolescent patients with tuberous sclerosis complex (TSC). Neonatal highly aggressive SEGCA is very rare. We report a 5-month-old child with TSC presenting with a cystic mass lesion in the left frontal lobe as well as multiple other periventricular masses. After initial conservative treatment, the child was readmitted with intractable seizures, a massive increase in the size of the left frontal lobe tumor and obstructive hydrocephalus. Despite surgical interventions, the child succumbed to the intracranial lesions. In this report, we discuss the challenges of managing SEGCA and the importance of further studies, including genetic studies, that may lead to a better understanding of its pathophysiology. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12053047     DOI: 10.1159/000058432

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  12 in total

1.  Subependymal giant cell astrocytoma--a clinicopathological study of 23 cases with special emphasis on histogenesis.

Authors:  Mehar Chand Sharma; Angela Mercy Ralte; Shailesh Gaekwad; Vani Santosh; S K Shankar; Chitra Sarkar
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

2.  Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.

Authors:  Joel S Katz; Hyman Frankel; Tracy Ma; David Zagzag; Benjamin Liechty; Bruria Ben Zeev; Michal Tzadok; Orrin Devinsky; Howard L Weiner; Jonathan Roth
Journal:  Childs Nerv Syst       Date:  2017-01-10       Impact factor: 1.475

Review 3.  Neurosurgical treatment of tuberous sclerosis complex lesions.

Authors:  Ignacio Pascual-Castroviejo
Journal:  Childs Nerv Syst       Date:  2011-05-24       Impact factor: 1.475

Review 4.  Surgical treatment of brain tumors in infants younger than six months of age and review of the literature.

Authors:  Shih-Shan Lang; Lauren A Beslow; Brandon Gabel; Alex R Judkins; Michael J Fisher; Leslie N Sutton; Phillip B Storm; Gregory G Heuer
Journal:  World Neurosurg       Date:  2011-11-07       Impact factor: 2.104

Review 5.  The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective.

Authors:  Romina Moavero; Mariangela Pinci; Roberta Bombardieri; Paolo Curatolo
Journal:  Childs Nerv Syst       Date:  2011-02-09       Impact factor: 1.475

6.  A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism.

Authors:  Tomotsugu Ichikawa; Akiko Wakisaka; Shigeru Daido; Soichiro Takao; Takashi Tamiya; Isao Date; Shoichi Koizumi; Yo Niida
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

Review 7.  Subependymal giant cell astrocytoma: current concepts, management, and future directions.

Authors:  Taohui Ouyang; Na Zhang; Thomas Benjamin; Long Wang; Jiantong Jiao; Yiqing Zhao; Jian Chen
Journal:  Childs Nerv Syst       Date:  2014-02-19       Impact factor: 1.475

8.  Congenital subependymal giant cell astrocytoma: clinical considerations and expression of radial glial cell markers in giant cells.

Authors:  Ji Hoon Phi; Sung-Hye Park; Jong Hee Chae; Ki Ho Hong; Sung Sup Park; Ji Hyun Kang; Jong Kwan Jun; Byung-Kyu Cho; Kyu-Chang Wang; Seung-Ki Kim
Journal:  Childs Nerv Syst       Date:  2008-07-16       Impact factor: 1.475

Review 9.  [Intracranial tumors in pediatric patients].

Authors:  W Reith; T Hagen
Journal:  Radiologe       Date:  2007-06       Impact factor: 0.635

Review 10.  [Supratentorial tumors in childhood].

Authors:  W Reith; I Grunwald; H Reinhard; N Graf
Journal:  Radiologe       Date:  2003-11       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.